We assessed the association of HMGB1 SNP genotypes with GC clinical outcome using the multivariate Cox regression analysis with adjustment for age, sex, tumor site, Lauren classification, differentiation, TNM stage and ACT (as shown in Table 1). This evidence concerns the gene HMGB1 and neoplasm.